Drug Trial Radar · NCT02388984
Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Last checked: Nov 19, 2026Latest source record: Mar 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
480
Planned (sponsor's estimate)
Start
May 2013
Primary completion
May 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Tasly Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 17, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of Compound Danshen Dripping Pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis).
Conditions
- Non-proliferative Diabetic Retinopathy
Interventions
Compound danshen dripping pillsDrug
Dosage form:pill. Dosage:20pills. Frequency:three times per day. Duration:24 weeks.
PlaceboDrug
Dosage form:pill. Dosage:20pills. Frequency:three times per day. Duration:24 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The total effective rate of Fundus changes, the severity of diabetic retinopathy change from baseline at the end of week 24 compared to placeboTime frame: 24weeks
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
Dongfang Hospital, Beijing University of Chinese Medicine
Beijing, Beijing Municipality, China
Southwest Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Guangzhou University of TCM
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Henan Institute of Ophthalmology
Zhengzhou, Henan, China
Hubei Provincial Hospital of TCM
Wuhan, Hubei, China
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, China
The First Hospital of Hunan University of Chinese Medicine
Changsha, Hunan, China
Jiangsu Province Hospital of TCM
Nanjing, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
The Affiliated Hospital of Changchun University of Chinese Medicine
Changchun, Jilin, China
Shenyang He Eye Hospital
Shenyang, Liaoning, China
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Teaching Hospital of Chengdu University of TCM
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.